Identifying optimal risk windows for self-controlled case series studies of vaccine safety

Statistics in Medicine

Volumn 30, Issue 7, 2011, Pages 742-752

  Xu, Stanley ^a   Zhang, Lijing ^a   Nelson, Jennifer C ^b,c   Zeng, Chan ^a   Mullooly, John ^d   Mcclure, David ^a   Glanz, Jason ^a  

^a KAISER PERMANENTE   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Center for Health Research   (United States)

Author keywords

Adverse events after immunization; Change point; Incidence rate ratio; Optimal risk window; Self controlled case series

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ACCURACY; ARTICLE; CHILD SAFETY; CURVE FITTING; DRUG SAFETY; FOLLOW UP; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MATHEMATICAL COMPUTING; MEASUREMENT ERROR; PROCESS MODEL; RISK ASSESSMENT; STATISTICAL ANALYSIS; VALIDATION PROCESS;

CLINICAL TRIALS AS TOPIC; COHORT STUDIES; COMPUTER SIMULATION; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; INCIDENCE; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; MODELS, STATISTICAL; ODDS RATIO; VACCINES;

EID: 79952607365     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.4125     Document Type: Article

References (34)

1. Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC. The vaccine safety datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics 1997; 99:765-73. DOI: 10.1542/peds.99.6.765.
2. Fine PM, Chen RT. Confounding in studies of adverse reactions to vaccines. American Journal of Epidemiology 1992; 136:121-135.
3. DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco BF, Mullooly JP, Jackson LA, Davis RL, Black SB, Shinefield HR, Marcy SM, Ward JI, Chen RT. Childhood vaccinations and risk of asthma. Pediatric Infectious Diseases Journal 2002; 21(6):498-504. DOI: 10.1097/00006454-200206000-00004.
4. Chen RT, Davis RL, Sheedy KM. Safety of immunizations. In Vaccines, Chapter 61 (4th edn), Plotkin SA, Orenstein WA (eds). WB Saunders Company: Philadelphia, PA, 2004.
5. Eriksen EM, Perlman JA, Miller A, Marcy SM, Lee H, Vadheim C, Zangwill KM, Chen RT, DeStefano F, Lewis E, Black S, Shinefield H, Ward JI. Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the Vaccine Safety Datalink Project. The Pediatric Infectious Disease Journal 2004; 23(7):656-662. DOI: 10.1097/01.inf.0000130953.08946.d0.
6. France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Archives of Pediatrics and Adolescent Medicine 2004; 158:1031-36. DOI: 10.1001/archpedi.158.11.1031.
7. Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F. Vaccine Safety Datalink Team. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Journal of the American Medical Association 2006; 296(16):1990-1997. DOI: 10.1001/jama.296.16.1990.
8. France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R. Vaccine Safety Datalink Team. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008; 121(3)e:687-92. DOI: 10.1542/peds.2007-1578.
9. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51:228-35. DOI: 10.2307/2533328.
10. Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. Journal of Clinical Epidemiology 2006; 59:808-818. DOI: 10.1016/j.jclinepi.2005.11.012.
11. Lerman PM. Fitting segmented regression models by grid search. Applied Statistics 1980; 29:77-84. DOI: 10.2307/2346413.
12. Kim HJ, Siegmund D. The likelihood ratio test for a change-point in simple linear regression. Biometrika 1989; 76:409-423. DOI: 10.1093/biomet/76.3.409.
13. Bai J. Estimating multiple breaks one at a time. Econometric Theory 1997; 13:315-352. DOI: 10.1017/S0266466600005831.
14. Bai J. Likelihood ratio tests for multiple structural changes. Journal of Econometrics 1999; 91:299-323. DOI: 10.1016/S03044076(98)00079-7.
15. Bai J, Perron P. Estimating and testing linear models with multiple structural change. Econometrica 2003; 66:47-48. DOI: 10.2307/2998540.
16. Matthews DE, Farewell VT. On testing for a constant hazard against a change-point alternative (Corr: V41 p1103). Biometrics 1982; 38:463-468. DOI: 10.2307/2530460.
17. Nguyen GS, Rogers G, Walker EA. Estimation in change-point hazard rate models. Biometrics 1984; 71:299-304. DOI: 10.1093/biomet/71.2.299.
18. Luo X. The asymptotic distribution of MLE of treatment lag threshold. Journal of Statistical Planning and Inference 1996; 53:33-61. DOI: 10.1016/0378-3758(95)00142-5.
19. Luo X, Turnbull B, Clark L. Likelihood ratio tests for a changepoint with survival data. Biometrika 1997; 84:555-565. DOI: 10.1093/biomet/84.3.555.
20. Pons O. Estimation in a Cox regression model with a change-point at an unknown time. Statistics 2002; 36:101-124. DOI: 10.1080/02331880212043.
21. Gijbels I, Gurler U. Estimation of a change point in a hazard function based on censored data. Lifetime Data Analysis 2003; 9:395-411. DOI: 10.1023/B:LIDA.0000012424.71723.9d.
22. Liu M, Lu W, Shao Y. A Monte Carlo approach for change-point detection in the Cox proportional hazards model. Statistics in Medicine 2008; 27(19):3894-909. DOI: 10.1002/sim.3214.
23. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. American Journal of Epidemiology 1996; 143:1165-1173.
24. Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Statistical Methods in Medical Research 2009; 18:7-26. DOI: 10.1177/0962280208092342.
25. SAS 9.1 SAS Institute Inc., Cary, NC, U.S.A., 2002-2003.
26. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Statistics in Medicine 2006; 25(10):1768-1797. DOI: 10.1002/sim.2302.
27. Farrington CP, Whitaker HJ. Semiparametric analysis of case series data (with Discussion). Applied Statistics 2006; 155:553-594. DOI: 10.1111/j.1467-9876.2006.00554.x.
28. Xu S, Gargiullo P, Mullooly J, McClure D, Hambidge S, Glanz J. Fitting parametric and semi-parametric conditional Poisson regression models with Cox's partial likelihood in self-controlled case series and matched cohort studies. Journal of Data Science 2010; 8:349-360.
29. Musonda P. The self-controlled case series method: performance and design in studies of vaccine safety. Ph.D. Thesis, The Open University, December 2006.
30. Miller E, Waight P, Farrington P, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Archives of Disease in Childhood 2001; 84:227-229. DOI: 10.1136/adc.84.3.227.
31. France EK, Glanz JM, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly J, Jackson L, Nordin J, Belongia E, Hohman K, Chen RT, Davis R. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008; 121:687-692. DOI: 10.1542/peds.2007-1578.
32. Cleveland WS, Devlin SJ, Grosse E. Regression by local fitting methods, properties, and computational algorithms. Journal of Econometrics 1988; 37:87-114. DOI: 10.1016/0304-4076(88)90077-2.
33. Cleveland WS, Grosse E. Computational methods for local regression. Statistics and Computing 1991; 1:47-62. DOI: 10.1007/BF01890836.
34. Platt R, Wilson M, Chan A, Benner J, Marchibroda J, McClellan M. The new sentinel network: improving the evidence of medical-product safety. The New England Journal of Medicine 2009; 361:645-647. DOI: 10.1056/NEJMp0905338.